{"id":56454,"date":"2025-07-09T20:28:27","date_gmt":"2025-07-09T18:28:27","guid":{"rendered":"https:\/\/www.fyb.de\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/"},"modified":"2025-07-09T20:28:27","modified_gmt":"2025-07-09T18:28:27","slug":"succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/","title":{"rendered":"Succession: SHS Capital acquires majority stake in Ackermann Instrumente"},"content":{"rendered":"<p>T\u00fcbingen\/ Riet\u00adheim-Weil\u00adheim \u2014 The health\u00adcare inves\u00adtor SHS Capi\u00adtal has acqui\u00adred a majo\u00adrity stake in Acker\u00admann Instru\u00admente GmbH. The aim of the invest\u00adment is to further expand Acker\u00adman\u00adn\u2019s core busi\u00adness and to estab\u00adlish a leading global medi\u00adcal tech\u00adno\u00adlogy group through targe\u00adted part\u00adner\u00adships with other compa\u00adnies in the region.&nbsp;<\/p>\n<p>Rolf Acker\u00admann will remain a mino\u00adrity share\u00adhol\u00adder. Peter Grassl will conti\u00adnue to lead Acker\u00admann Instru\u00admente GmbH as Mana\u00adging Direc\u00adtor and conti\u00adnue on the growth path.&nbsp;<\/p>\n<p><strong>Acker\u00admann Instru\u00admente<\/strong>, based near Tutt\u00adlin\u00adgen, is a leading manu\u00adfac\u00adtu\u00adrer of high-quality surgi\u00adcal instru\u00adments with a focus on endo\u00adscopy, implan\u00adto\u00adlogy and gene\u00adral surgery. Verti\u00adcally inte\u00adgra\u00adted in-house produc\u00adtion ensu\u00adres high product quality, cost effi\u00adci\u00adency and full control along the value chain. Thanks to its strong regu\u00adla\u00adtory exper\u00adtise and opera\u00adtio\u00adnal flexi\u00adbi\u00adlity, Acker\u00admann has estab\u00adlished itself as a relia\u00adble part\u00adner for medi\u00adcal profes\u00adsio\u00adnals and MedTech compa\u00adnies. Conti\u00adnuous sales growth and a diver\u00adsi\u00adfied and growing custo\u00admer base make the company an attrac\u00adtive part\u00adner to bene\u00adfit from the global trend towards mini\u00admally inva\u00adsive surgi\u00adcal proce\u00addu\u00adres \u2014 espe\u00adci\u00adally in emer\u00adging markets.&nbsp;<\/p>\n<p>SHS sees great poten\u00adtial in Acker\u00adman\u00adn\u2019s scalable busi\u00adness model and in the company\u2019s inter\u00adna\u00adtio\u00adnal growth stra\u00adtegy. In the coming years, Acker\u00admann will conti\u00adnue to streng\u00adthen its core busi\u00adness, expand its market presence and drive inno\u00adva\u00adtion in a targe\u00adted manner.&nbsp;<\/p>\n<p>In an incre\u00adasingly conso\u00adli\u00adda\u00adting Euro\u00adpean MedTech market, driven by MDR requi\u00adre\u00adments and corpo\u00adrate succes\u00adsion, Acker\u00adman\u00adn\u2019s global distri\u00adbu\u00adtion chan\u00adnels provide an attrac\u00adtive plat\u00adform for stra\u00adte\u00adgic part\u00adner\u00adships and acqui\u00adsi\u00adti\u00adons in the region and beyond. SHS aims to build a leading medtech group with other compa\u00adnies in the region and beyond to realize distri\u00adbu\u00adtion syner\u00adgies based on Acker\u00adman\u00adn\u2019s global distri\u00adbu\u00adtor network and econo\u00admies of scale rela\u00adted to the Medi\u00adcal Device Regu\u00adla\u00adtion (MDR) <\/p>\n<p>\u201cSHS is the right part\u00adner for company succes\u00adsion in medi\u00adcal tech\u00adno\u00adlogy,\u201d says <strong>Rolf Acker\u00admann, former majo\u00adrity share\u00adhol\u00adder of Acker\u00admann Instru\u00admente<\/strong> GmbH. \u201cA trust\u00adwor\u00adthy address with a deep under\u00adstan\u00adding of the indus\u00adtry and a long-term approach \u2014 that\u2019s what convin\u00adced&nbsp;us.\u201d&nbsp;<\/p>\n<p>\u201cWith SHS, we have the oppor\u00adtu\u00adnity to posi\u00adtion Acker\u00admann as a plat\u00adform for buil\u00adding a powerful medi\u00adcal tech\u00adno\u00adlogy group,\u201d says <strong>Mana\u00adging Direc\u00adtor Peter Grassl<\/strong>. \u201cThe combi\u00adna\u00adtion of regu\u00adla\u00adtory pres\u00adsure from the MDR, inter\u00adna\u00adtio\u00adna\u00adliza\u00adtion poten\u00adtial and possi\u00adble econo\u00admies of scale makes this step stra\u00adte\u00adgi\u00adcally sensi\u00adble for many companies.\u201d&nbsp;<\/p>\n<p><strong>Dr. Corne\u00adlius Maas, Part\u00adner at SHS Capi\u00adtal<\/strong>, adds: \u201cAcker\u00admann is <em>a hidden cham\u00adpion<\/em> of German medi\u00adcal tech\u00adno\u00adlogy \u2014 exactly the kind of company we part\u00adner with. The team has built a highly profi\u00adta\u00adble, inter\u00adna\u00adtio\u00adnally opera\u00adting company that offers a compel\u00adling value propo\u00adsi\u00adtion to users and indus\u00adtry part\u00adners alike. We look forward to shaping the next chap\u00adter of growth toge\u00adther, both orga\u00adni\u00adcally and through targe\u00adted part\u00adner\u00adships and acquisitions.\u201d&nbsp;<\/p>\n<p><strong><br>\nAbout Acker\u00admann Instru\u00admente&nbsp;GmbH<\/strong><\/p>\n<p>For over seven deca\u00addes, the Acker\u00admann Group has been deve\u00adlo\u00adping, manu\u00adfac\u00adtu\u00adring and distri\u00adbu\u00adting solu\u00adti\u00adons of the highest quality for a wide range of surgi\u00adcal appli\u00adca\u00adti\u00adons, parti\u00adcu\u00adlarly in the fields of open and mini\u00admally inva\u00adsive surgery, but also liga\u00adture and spinal implants. \u2014 In addi\u00adtion to our strong brands, as an OEM manu\u00adfac\u00adtu\u00adrer we are behind a large number of unique products and are proud of our global market leadership.&nbsp;<\/p>\n<p>True to our INNOVATING TRADITION vision, our goal has always been to offer our custo\u00admers and users indus\u00adtry-leading added value not only through conti\u00adnuous inno\u00adva\u00adtion in our products and proces\u00adses, but also to never lose sight of our roots and to preserve the craft\u00adsman\u00adship perfec\u00adted over gene\u00adra\u00adti\u00adons as an estab\u00adlished family business.<\/p>\n<p>This enables us to create a respon\u00adsi\u00adble home for our employees and improve clini\u00adcal outco\u00admes every day in over 100 count\u00adries around the world. \u2014 <a href=\"http:\/\/www.ackermannsurgical.com\/\"><em>www.<\/em><\/a><em><a href=\"https:\/\/www.ackermannsurgical.com\/de\" target=\"_blank\" rel=\"noreferrer noopener\">acker\u00admann\u00adsur\u00adgi\u00adcal<\/a><\/em><a href=\"http:\/\/www.ackermannsurgical.com\/\"><em>.com<\/em><\/a> <\/p>\n<p><strong>About SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment&nbsp;mbH<\/strong><\/p>\n<p>SHS, an indus\u00adtry inves\u00adtor, is a private equity firm foun\u00added in 1993 that makes invest\u00adments in health\u00adcare compa\u00adnies in Europe. The focus of invest\u00adments is on expan\u00adsion finan\u00adcing, share\u00adhol\u00adder chan\u00adges and succes\u00adsion situa\u00adtions. \u201cBuil\u00adding Euro\u00adpean Health\u00adcare Cham\u00adpi\u00adons\u201d is the invest\u00adment philo\u00adso\u00adphy accor\u00adding to which SHS finan\u00adces and deve\u00adlops port\u00adfo\u00adlio compa\u00adnies. The T\u00fcbin\u00adgen-based inves\u00adtor is taking both mino\u00adrity and majo\u00adrity stakes.<\/p>\n<p>SHS funds\u2019 natio\u00adnal and inter\u00adna\u00adtio\u00adnal inves\u00adtors include pension funds, funds of funds, foun\u00adda\u00adti\u00adons, family offices, stra\u00adte\u00adgic inves\u00adtors, entre\u00adpre\u00adneurs and the SHS manage\u00adment team. The equity or equity-like invest\u00adment of the AIF amounts to up to \u20ac 50 million. Volu\u00admes in excess of this can be reali\u00adzed with a network of co-inves\u00adtors.  When making invest\u00adment decis\u00adi\u00adons, SHS places strong empha\u00adsis on conside\u00adring ESG aspects and is ther\u00ade\u00adfore commit\u00adted to the UN PRI guide\u00adlines. SHS is curr\u00adently inves\u00adt\u00ading from its sixth fund, which was laun\u00adched in 2022 and has a volume of around \u20ac 270m. \u2014 <em>www.shs-capital.eu<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\u00fcbingen\/ Riet\u00adheim-Weil\u00adheim \u2014 The health\u00adcare inves\u00adtor SHS Capi\u00adtal has acqui\u00adred a majo\u00adrity stake in Acker\u00admann Instru\u00admente GmbH. The aim of the invest\u00adment is to further expand Acker\u00adman\u00adn\u2019s core busi\u00adness and to estab\u00adlish a leading global medi\u00adcal tech\u00adno\u00adlogy group through targe\u00adted part\u00adner\u00adships with other compa\u00adnies in the region.&nbsp; Rolf Acker\u00admann will remain a mino\u00adrity share\u00adhol\u00adder.&nbsp;Peter&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":56452,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-56454","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Succession: SHS Capital acquires majority stake in Ackermann Instrumente - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"T\u00fcbingen\/ Rietheim-Weilheim - The healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The aim of the investment is to further expand Ackermann&#039;s core business and to establish a leading global medical technology group through targeted partnerships with other companies in the region.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Succession: SHS Capital acquires majority stake in Ackermann Instrumente - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"T\u00fcbingen\/ Rietheim-Weilheim - The healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The aim of the investment is to further expand Ackermann&#039;s core business and to establish a leading global medical technology group through targeted partnerships with other companies in the region.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-09T18:28:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png\" \/>\n\t<meta property=\"og:image:width\" content=\"648\" \/>\n\t<meta property=\"og:image:height\" content=\"383\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Succession: SHS Capital acquires majority stake in Ackermann Instrumente\",\"datePublished\":\"2025-07-09T18:28:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/\"},\"wordCount\":756,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/\",\"url\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/\",\"name\":\"Succession: SHS Capital acquires majority stake in Ackermann Instrumente - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png\",\"datePublished\":\"2025-07-09T18:28:27+00:00\",\"description\":\"T\u00fcbingen\/ Rietheim-Weilheim - The healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The aim of the investment is to further expand Ackermann's core business and to establish a leading global medical technology group through targeted partnerships with other companies in the region.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png\",\"width\":648,\"height\":383},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Succession: SHS Capital acquires majority stake in Ackermann Instrumente\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Succession: SHS Capital acquires majority stake in Ackermann Instrumente - FYB Financial Yearbook","description":"T\u00fcbingen\/ Rietheim-Weilheim - The healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The aim of the investment is to further expand Ackermann's core business and to establish a leading global medical technology group through targeted partnerships with other companies in the region.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/","og_locale":"en_US","og_type":"article","og_title":"Succession: SHS Capital acquires majority stake in Ackermann Instrumente - FYB Financial Yearbook","og_description":"T\u00fcbingen\/ Rietheim-Weilheim - The healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The aim of the investment is to further expand Ackermann's core business and to establish a leading global medical technology group through targeted partnerships with other companies in the region.","og_url":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2025-07-09T18:28:27+00:00","og_image":[{"width":648,"height":383,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png","type":"image\/png"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Succession: SHS Capital acquires majority stake in Ackermann Instrumente","datePublished":"2025-07-09T18:28:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/"},"wordCount":756,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/","url":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/","name":"Succession: SHS Capital acquires majority stake in Ackermann Instrumente - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png","datePublished":"2025-07-09T18:28:27+00:00","description":"T\u00fcbingen\/ Rietheim-Weilheim - The healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The aim of the investment is to further expand Ackermann's core business and to establish a leading global medical technology group through targeted partnerships with other companies in the region.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/07\/juergen-maas-shs-capital-foto-shs-capital.png","width":648,"height":383},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/succession-shs-capital-acquires-majority-stake-in-ackermann-instrumente\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Succession: SHS Capital acquires majority stake in Ackermann Instrumente"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/56454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=56454"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/56454\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/56452"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=56454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=56454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=56454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}